SCHEMBL2494549

SCHEMBL2494549

Oc1ccccc1[C](c1ccccc1O)c1ccccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.57
ALDH1A1 P00352 7/20 0.57
KDM4E B2RXH2 6/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
CA12 O43570 2/20 0.57
CA2 P00918 2/20 0.57
CA4 P22748 2/20 0.57
CA14 Q9ULX7 2/20 0.57
CA1 P00915 1/20 0.57
HMGB1 P09429 1/20 0.57
CA6 P23280 1/20 0.57
CA7 P43166 1/20 0.57
CA9 Q16790 1/20 0.57
NAPRT Q6XQN6 1/20 0.57
HSD17B10 Q99714 6/20 0.56
MAPT P10636 4/20 0.56
LMNA P02545 4/20 0.56
ALOX15 P16050 4/20 0.56
NPC1 O15118 3/20 0.56
HIF1A Q16665 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4196339 0.83 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA12
SCHEMBL324637 0.78 HPGD (0.62) HPGDALDH1A1KDM4ESMN1; SMN2CA12
SCHEMBL10963480 0.75 HPGD (0.52) HPGDALDH1A1KDM4ESMN1; SMN2CA12
2,2'-Dihydroxybenzphenone SCHEMBL18422 0.75 HPGD (0.67) HPGDALDH1A1KDM4ESMN1; SMN2CA12
2,2'-Dihydroxybenzphenone SCHEMBL29572496 0.75 HPGD (0.67) HPGDALDH1A1KDM4ESMN1; SMN2CA12
SCHEMBL17474473 0.75 HPGD (0.52) HPGDALDH1A1KDM4ESMN1; SMN2CA12
SCHEMBL9130593 0.75 HPGD (0.52) HPGDALDH1A1KDM4ESMN1; SMN2CA12
SCHEMBL10736476 0.75 HPGD (0.56) HPGDALDH1A1KDM4ESMN1; SMN2CA12
SCHEMBL9797513 0.75 KDM4E (0.67) HPGDALDH1A1KDM4ESMN1; SMN2CA12
SCHEMBL4801020 0.75 HPGD (0.52) HPGDALDH1A1KDM4ESMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
JP-2007031583-A AROMATIC POLYCARBONATE RESIN COMPOSITION TEIJIN CHEM LTD 2007-02-08 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH HPGD 1749/4885ALDH1A1 1292/4885KDM4E 2772/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 HPGD 1563/4885ALDH1A1 1031/4885KDM4E 3096/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R HPGD 1618/4885ALDH1A1 1187/4885KDM4E 3125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.